Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
Scopien Signs Deal to Take Control of Cannabis Strategic Ventures

Scopien Signs Deal to Take Control of Cannabis Strategic Ventures

BitgetBitget2026/11/03 14:03
  • Scopien Technologies signed a binding letter of intent to acquire voting control of Cannabis Strategic Ventures and contribute its operating business.
  • Control would pass through the transfer of Series B Super Voting Preferred Stock, with closing targeted for November 30, 2026.
  • Scopien, an AI-enabled business software platform, would appoint the company’s officers and directors at closing.
  • The company terminated its September 10, 2026, non-binding agreement to acquire substantially all Adport intellectual property and operating assets.
  • Plans include completing audits and filing a registration statement within six months of closing, targeting an eventual Nasdaq or NYSE listing.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Cannabis Strategic Ventures published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202611030900PRIMZONEFULLFEED9868322) on November 03, 2026, and is solely responsible for the information contained therein.

0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

"No-drill dental filling" company vVardis (VVVV.US) launches a $214 million US IPO, scheduled to be priced this week.

Dental treatment company vVardis has announced the terms for its $214 million US IPO.

智通财经•2026/11/09 06:41
"No-drill dental filling" company vVardis (VVVV.US) launches a $214 million US IPO, scheduled to be priced this week.

Wegovy improves multiple liver indicators in non-obese liver disease patients, and Novo Nordisk (NVO.US) is expected to expand its market beyond weight loss

Novo Nordisk reports that some patients treated with Wegovy have shown improvements in liver conditions.

智通财经•2026/11/09 06:41
Wegovy improves multiple liver indicators in non-obese liver disease patients, and Novo Nordisk (NVO.US) is expected to expand its market beyond weight loss